Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

208 projects found matching your search criteria :

  1. IFIT proteins in the regulation of inflammatory responses

    Call: OPUS 21 , Panel: NZ2

    Principal investigator: dr Maria Wiktoria Górna

    Uniwersytet Warszawski, Wydział Chemii

  2. Mitochondria-targeting conjugates as a new anticancer agents

    Call: OPUS 21 , Panel: ST4

    Principal investigator: prof. Adam Włodzimierz Huczyński

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Chemii

  3. New 3-methoxypropanamide derivatives in search of effective substances for the treatment of neurological diseases - epil...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Marcin Konrad Jakubiec

    Uniwersytet Jagielloński, Collegium Medicum

  4. Development of new implantable drug forms, biodegradable nanofibers containing selected betulin derivatives in order to ...

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: prof. Janusz Edward Kasperczyk

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Farmaceutycznych w Sosnowcu

  5. Effect of SSR 504734, a selective glycine transporter type 1 inhibitor, on seizure activity and therapeutic efficacy of ...

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: prof. Piotr Wiktor Wlaź

    Uniwersytet Marii Curie-Skłodowskiej w Lublinie, Wydział Biologii i Biotechnologii

  6. Novel BODIPY derivatives and ruthenium complexes conjugates as photosensitizers for bacterial inactivation in the in viv...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Weronika Porolnik

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  7. Synthetic epidermal growth factor receptor inhibitor conjugated with nobel metal nanoparticles as a potential drug for t...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Shaoshan Mai

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

  8. New antimycotic polycations - synthesis, chemical characterization, toxicity and antifungal spectrum

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: dr Kamil Krzysztof Kamiński

    Uniwersytet Jagielloński, Wydział Chemii

  9. Towards the integrated molecular modelling – machine learning (MM-ML)" computational method for supporting the design of...

    Call: SHENG 2 , Panel: ST5

    Principal investigator: prof. Tomasz Puzyn

    Uniwersytet Gdański, Wydział Chemii

  10. Tryptophan Metabolites and their Metal Complexes as new drugs for Colorectal Cancer Treatment and Human Gut Microbiota R...

    Call: OPUS 20 , Panel: ST4

    Principal investigator: prof. Beata Izabella Godlewska-Żyłkiewicz

    Uniwersytet w Białymstoku, Wydział Chemii

  11. Prenatal exposure to glucocorticoids as a risk factor for depression - the importance of epigenetic mechanisms in the br...

    Call: SONATA 16 , Panel: NZ7

    Principal investigator: dr Katarzyna Elżbieta Głombik

    Instytut Farmakologii PAN

  12. Molecular profiling of novel antipsychotic drug candidates

    Call: OPUS 20 , Panel: NZ7

    Principal investigator: dr hab. Jan Manuel Rodriguez Parkitna

    Instytut Farmakologii PAN

  13. Drug metabolizing enzymes (DMEs) in liver pathology, proteomic characteristics, transcriptional and epigenetic regulatio...

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: prof. Marek Droździk

    Pomorski Uniwersytet Medyczny w Szczecinie

  14. Schisandra henryi C.B. Clarke - increasing the production of secondary metabolites by biotechnological methods, and eval...

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Karolina Anna Jafernik

    Uniwersytet Jagielloński, Collegium Medicum

  15. Bioremediation of water pollution caused by drugs and cosmetics by Cunninghamella fungi - a biotechnological strategy fo...

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: dr Karolina Anna Słoczyńska

    Uniwersytet Jagielloński, Collegium Medicum

  16. Research on white-rot fungi ability to remove cytostatic drugs on an example of: bleomycin and vincristine

    Call: PRELUDIUM 19 , Panel: ST8

    Principal investigator: dr Marcelina Karolina Jureczko

    Politechnika Śląska, Wydział Inżynierii Środowiska i Energetyki

  17. Bioactivity screening of antiparasitic drugs in vitro - transcriptomic and metabolomic studies on parasitic nematode Ani...

    Call: PRELUDIUM 19 , Panel: NZ9

    Principal investigator: Iwona Polak

    Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Biologii i Biotechnologii

  18. Do potential new MRGPRX2 ligands induce mastocytes degranulation in human?

    Call: OPUS 18 , Panel: NZ5

    Principal investigator: dr hab. Grzegorz Porębski

    Uniwersytet Jagielloński, Collegium Medicum

  19. Insulin – metallacarborane conjugates: A new strategy to enhance the biological efficacy of peptide drugs

    Call: PRELUDIUM BIS 1 , Panel: NZ7

    Principal investigator: dr hab. Tomasz Marek Goszczyński

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  20. Modulation of exosome production to support anti-cancer treatment

    Call: OPUS 18 , Panel: NZ7

    Principal investigator: dr Liliana Monika Czernek

    Centrum Badań Molekularnych i Makromolekularnych PAN

  21. Estimation of susceptibility and remediation potential of green algae towards non-steroidal anti-inflammatory drugs dete...

    Call: OPUS 18 , Panel: NZ9

    Principal investigator: dr hab. Anna Marta Aksmann

    Uniwersytet Gdański, Wydział Biologii

  22. Galactosylceramide as a regulator of apoptotic gene expression and modulator of drug resistance in breast cancer cells.

    Call: OPUS 18 , Panel: NZ5

    Principal investigator: prof. Maciej Ugorski

    Uniwersytet Przyrodniczy we Wrocławiu, Wydział Medycyny Weterynaryjnej

  23. Novel chemoenzymatic strategies in asymmetric synthesis of the selected pharmaceuticals using recombinant oxydoreductase...

    Call: SONATA 15 , Panel: ST4

    Principal investigator: dr Paweł Borowiecki

    Politechnika Warszawska

  24. Gankyrin protein as a new potential therapeutic target in multiple myeloma

    Call: OPUS 18 , Panel: NZ5

    Principal investigator: dr hab. Irena Misiewicz-Krzemińska

    Instytut Hematologii i Transfuzjologii

  25. The influence of microplastics on the toxicity and fate of selected antidepressants

    Call: OPUS 18 , Panel: NZ8

    Principal investigator: prof. Grzegorz Leszek Nałęcz-Jawecki

    Warszawski Uniwersytet Medyczny

  26. Lipophilic Prodrug Charge Masking (LPCM) as a novel strategy to enhance oral bioavailability of charged active peptides....

    Call: SONATA 15 , Panel: NZ7

    Principal investigator: dr Agata Elżbieta Gitlin-Domagalska

    Uniwersytet Gdański, Wydział Chemii

  27. Lactoferrin and versatile polymers as a tool for selective and targeted delivery of anticancer hydrophobic drugs in the ...

    Call: PRELUDIUM 18 , Panel: NZ7

    Principal investigator: Przemysław Krzysztof Gajda-Morszewski

    Uniwersytet Jagielloński, Wydział Chemii

  28. DEVELOPMENT OF NEW CLASS PHOTOACTIVATED ANTICANCER-ANTIFUNGAL COMPOUNDS: CONJUGATES OF GOLD NANOPARTICLE-SUPPORTED QUINO...

    Call: OPUS 17 , Panel: NZ7

    Principal investigator: dr hab. Oleh M. Demchuk

    Katolicki Uniwersytet Lubelski Jana Pawła II, Wydział Medyczny

  29. Rola tlenu i insuliny w odpowiedzi komórek czerniaka na leki celowane in vitro

    Call: ETIUDA 7 , Panel: NZ3

    Principal investigator: Marta Ośrodek

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  30. Evaluation of the effects of long-term administration of new anticonvulsant drug-candidate.

    Call: PRELUDIUM 16 , Panel: NZ7

    Principal investigator: dr Anna Łucja Makuch-Kocka

    Uniwersytet Medyczny w Lublinie, Wydział Nauk o Zdrowiu

  31. Prognostic value of platelet-derived microRNAs in patients with acute coronary syndrome treated with novel P2Y12 recepto...

    Call: PRELUDIUM 16 , Panel: NZ7

    Principal investigator: dr hab. Aleksandra Gąsecka-van der Pol

    Warszawski Uniwersytet Medyczny, I Wydział Lekarski

  32. Novel pharmacological strategies for the treatment of depression

    Call: OPUS 16 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Młyniec

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  33. Dual ionophores as multitarget agents against pancreatic cancer

    Call: OPUS 16 , Panel: NZ7

    Principal investigator: dr hab. Robert Musioł

    UNIWERSYTET ŚLĄSKI, Wydział Matematyki, Fizyki i Chemii

  34. Hydrogels composed of dynamic cross-links of controlled diffusivity and enhanced solubility of drugs for gynecological t...

    Call: SONATA BIS 8 , Panel: ST5

    Principal investigator: dr hab. Monika Gosecka

    Centrum Badań Molekularnych i Makromolekularnych PAN

  35. Microbiological degradation pathway of diclofenac by strain from the Pseudomonas genus

    Call: PRELUDIUM 15 , Panel: NZ9

    Principal investigator: dr Joanna Paulina Żur-Pińska

    UNIWERSYTET ŚLĄSKI, Wydział Nauk Przyrodniczych

  36. Fighting antibiotic-resistant superbugs with anti-persister compounds targeting the strigent response

    Call: UNISONO , Panel: NZ6

    Principal investigator: dr hab. Ewa Laskowska

    Uniwersytet Gdański

  37. Influence of immobilization on metabolic activity and sensitivity on non-steroidal anti-inflammatory drugs of selected b...

    Call: OPUS 15 , Panel: NZ9

    Principal investigator: dr hab. Urszula Irena Guzik

    UNIWERSYTET ŚLĄSKI, Wydział Nauk Przyrodniczych

  38. New usnic acid derivatives as anticancer therapeutics

    Call: HARMONIA 9 , Panel: NZ7

    Principal investigator: prof. Anna Herman-Antosiewicz

    Uniwersytet Gdański, Wydział Biologii

  39. The role of insulin signaling in melanoma maintenance and response to targeted therapeutics

    Call: PRELUDIUM 13 , Panel: NZ3

    Principal investigator: Marta Osrodek

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  40. Exosome biosensors - new tools in cancer screening, diagnostics and development of targeted drug delivery system

    Call: OPUS 13 , Panel: ST4

    Principal investigator: dr hab. Magdalena Stobiecka

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Instytut Biologii

  41. DNA methylation as a modulating factor of response to thiopurine drugs in patients with inflammatory bowel disease

    Call: OPUS 13 , Panel: NZ5

    Principal investigator: prof. Jarosław Mirosław Walkowiak

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Lekarski I

  42. Biodegradation of selected nootropic drugs and evaluation of their metabolic pathways in context of sewage epidemiology

    Call: PRELUDIUM 13 , Panel: NZ9

    Principal investigator: Marta Helena Woźniak-Karczewska

    Politechnika Poznańska, Wydział Technologii Chemicznej

  43. Legal model of biosimilar medicinal products

    Call: PRELUDIUM 13 , Panel: HS5

    Principal investigator: Zbigniew Więckowski

    Uniwersytet Kardynała Stefana Wyszyńskiego w Warszawie, Wydział Prawa i Administracji

  44. Novel ligands of histamine receptor H4 as potential anti-allergic and anti-inflammatory drugs

    Call: OPUS 13 , Panel: NZ7

    Principal investigator: prof. Sławomir Hubert Filipek

    Uniwersytet Warszawski, Wydział Chemii

  45. Pharmacological and optogenetic investigation of the mechanism of action of Deep Brain Stimulation of the ventromedial p...

    Call: OPUS 13 , Panel: NZ7

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii PAN

  46. Zinc Deficiency: An essential Variable for the Induction od Resistance to Antidepressants

    Call: PRELUDIUM 13 , Panel: NZ5

    Principal investigator: dr Anna Maria Rafało-Ulińska

    Instytut Farmakologii PAN

  47. Characterization of clozapine and risperidone mechnism of action at the cell nucleus level

    Call: OPUS 13 , Panel: NZ4

    Principal investigator: dr hab. Sylwia Kędracka-Krok

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  48. Regulation of alternative Dclk1 kinase gene isoforms by psychotropic drugs

    Call: PRELUDIUM 12 , Panel: NZ3

    Principal investigator: Magdalena Agata Zygmunt

    Instytut Farmakologii PAN

  49. Role of oxidative stress and ceramide in the pathogenesis of depression and in the mechanizm of action of antidepressant...

    Call: PRELUDIUM 12 , Panel: NZ5

    Principal investigator: Justyna Józefa Brodowicz

    Instytut Farmakologii PAN

  50. Evaluation of interactions of aripiprazole, the atypical amtipsychotic drug, with the selected antidepressants in the ra...

    Call: OPUS 12 , Panel: NZ7

    Principal investigator: dr hab. Zofia Maria Rogóż

    Instytut Farmakologii PAN

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy